Several studies have shown a link between IL18 and cancer, specifically in pancreatic ductal adenocarcinoma (PDAC), where high levels of IL18 are associated with increased mortality and poor disease outcomes (Yamanishi et al., 2023). This evidence concerns the gene IL18 and cancer.